A detailed history of Vanguard Group Inc transactions in Liva Nova PLC stock. As of the latest transaction made, Vanguard Group Inc holds 1,832,987 shares of LIVN stock, worth $100 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,832,987
Previous 1,770,507 3.53%
Holding current value
$100 Million
Previous $91.6 Million 11.93%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$48.6 - $57.12 $3.04 Million - $3.57 Million
62,480 Added 3.53%
1,832,987 $103 Million
Q4 2023

Feb 14, 2024

BUY
$43.45 - $53.66 $9,993 - $12,341
230 Added 0.01%
1,770,507 $91.6 Million
Q3 2023

Nov 14, 2023

BUY
$50.12 - $58.87 $5.02 Million - $5.89 Million
100,133 Added 6.0%
1,770,277 $93.6 Million
Q2 2023

Aug 14, 2023

BUY
$42.28 - $51.43 $3.23 Million - $3.93 Million
76,433 Added 4.8%
1,670,144 $85.9 Million
Q1 2023

May 15, 2023

BUY
$40.84 - $58.14 $4.57 Million - $6.5 Million
111,791 Added 7.54%
1,593,711 $69.5 Million
Q4 2022

Feb 10, 2023

BUY
$43.88 - $56.16 $4.99 Million - $6.39 Million
113,709 Added 8.31%
1,481,920 $82.3 Million
Q3 2022

Nov 14, 2022

SELL
$48.37 - $66.5 $8,319 - $11,438
-172 Reduced 0.01%
1,368,211 $69.5 Million
Q2 2022

Aug 12, 2022

BUY
$57.25 - $86.63 $1.25 Million - $1.89 Million
21,808 Added 1.62%
1,368,383 $85.5 Million
Q1 2022

May 13, 2022

BUY
$71.02 - $86.99 $815,238 - $998,558
11,479 Added 0.86%
1,346,575 $110 Million
Q4 2021

Feb 14, 2022

BUY
$76.72 - $92.68 $767,583 - $927,263
10,005 Added 0.76%
1,335,096 $117 Million
Q3 2021

Nov 12, 2021

BUY
$76.02 - $88.62 $6.13 Million - $7.14 Million
80,621 Added 6.48%
1,325,091 $105 Million
Q2 2021

Aug 13, 2021

BUY
$73.44 - $87.01 $91.4 Million - $108 Million
1,244,470 New
1,244,470 $105 Million

Others Institutions Holding LIVN

About LivaNova PLC


  • Ticker LIVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,545,700
  • Market Cap $2.94B
  • Description
  • LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...
More about LIVN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.